EUVIMEDEUVIMED entdecken
Crossref

The treatment of Tofacitinib for rosacea through the inhibition of the JAK/STAT signaling pathway

Rui Sun, Huiping Fan, Jiayun Liu, Guomin Gao, Chengqi Liu, Dong Zhang, Weiyuan Ma

Archives of Dermatological Research · 2024

DOI: 10.1007/s00403-024-03314-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Dermatological Research, 2024. Verfasst von Rui Sun und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Affiliated Hospital of Shandong Second Medical University, School of Clinical Medicine, Shandong Second Medical University…. Hauptthemen laut MEDLINE: Piperidines, Pyrimidines, Rosacea, Signal Transduction. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PiperidinesPyrimidinesRosaceaSignal TransductionAdultAnimalsFemaleHumansMaleMiceMiddle AgedAdministration, OralAdministration, TopicalCD4-Positive T-LymphocytesDisease Models, AnimalJanus Kinase InhibitorsJanus KinasesMast CellsPyrrolesSkinSTAT Transcription FactorsSTAT1 Transcription Factor

Stichwörter der Autor:innen

LL37Mouse modelRosaceaSTATTofacitinib

Substanzen

Janus Kinase InhibitorsJanus KinasesPiperidinesPyrimidinesPyrrolesSTAT Transcription FactorsSTAT1 Transcription Factortofacitinib

Autor:innen und Institutionen

  • Department of Dermatology, Affiliated Hospital of Shandong Second Medical University, School of Clinical Medicine, Shandong Second Medical University, Weifang, Shandong, China.
  • Department of Dermatology, Affiliated Hospital of Shandong Second Medical University, School of Clinical Medicine, Shandong Second Medical University, Weifang, Shandong, China. dongdong.zd@163.com.
  • Department of Dermatology, Affiliated Hospital of Shandong Second Medical University, School of Clinical Medicine, Shandong Second Medical University, Weifang, Shandong, China. fymaweiyuan@sdsmu.edu.cn.

Zitieren

APA

Sun, R., Fan, H., Liu, J., Gao, G., Liu, C., Zhang, D., & Ma, W. (2024). The treatment of Tofacitinib for rosacea through the inhibition of the JAK/STAT signaling pathway. Archives of Dermatological Research. https://doi.org/10.1007/s00403-024-03314-4

Vancouver

Sun R, Fan H, Liu J, Gao G, Liu C, Zhang D, et al. The treatment of Tofacitinib for rosacea through the inhibition of the JAK/STAT signaling pathway. Archives of Dermatological Research. 2024. doi:10.1007/s00403-024-03314-4

BibTeX
@article{Sun2024,
  author = {Sun, Rui and Fan, Huiping and Liu, Jiayun and Gao, Guomin and Liu, Chengqi and Zhang, Dong and Ma, Weiyuan},
  title = {The treatment of Tofacitinib for rosacea through the inhibition of the JAK/STAT signaling pathway},
  journal = {Archives of Dermatological Research},
  year = {2024},
  doi = {10.1007/s00403-024-03314-4}
}
Kostenlos starten →